The effects of interferon beta-1a on proton MR spectroscopic imaging in patients with multiple sclerosis, a controlled study, preliminary results

International Journal of Neuroscience

Volumn 118, Issue 12, 2008, Pages 1645-1658

  Toprak, Münire Kilinç ^a   Çakir, Banu ^a   Ulu, E Meltem Kayahan ^a   Arat, Zübeyde ^a   Benli, Ülkü Sibel ^a   Can, Ufuk ^a   Aǧildere, Muhteşem ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Interferon beta 1a; MRSI; Multiple sclerosis; NAWM; WM

Indexed keywords

BETA1A INTERFERON; CHOLINE; CREATININE; METHYLPREDNISOLONE;

ADULT; ARTICLE; BRAIN DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLITE; MULTIPLE SCLEROSIS; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADJUVANTS, IMMUNOLOGIC; ADULT; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM; CHOLINE; CREATINE; DISABILITY EVALUATION; FEMALE; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 54349104028     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450802309680     Document Type: Article

References (36)

1. Allen, I. V., & McKeown, S. R. (1979). A histological, histochemical, and biochemical study of the macroscopically normal white matter in multiple sclerosis. Journal of the Neurological Sciences, 41(1), 81-91.
2. Armspach, J. P., Gounot, D., Rumbach, L., & Chambron, J. (1991). In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magnetic Resonance Imaging, 9(1), 107-113.
3. Arnold, D. L., Matthews, P. M., Francis, G. S., O'Connor, J., & Antel, J. P. (1992). Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Annals of Neurology, 31(3), 235-241.
4. Arnold, D. L., Riess, G. T., Matthews, P. M., Francis, G. S., Collins, D. L., Wolfson, C., et al. (1994). Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Annals of Neurology, 36(1), 76-82.
5. Bitsch, A., Bruhn, H., Vougioukas, V., Stringaris, A., Lassmann, H., Frahm, J., et al. (1999). Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. American Journal of Neuroradiology, 20(9), 1619-1627.
6. Brenner, R. E., Munro, P. M., Williams, S. C., Bell, J. D., Barker, G. J., Hawkins, C. P., et al. (1993). The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magnetic Resonance in Medicine, 29(6), 737-745.
7. Brex, P. A., Gomez-Anson, B., Parker, G. J., Molyneux, P. D., Miszkiel, K. A., Barker, G. J., et al. (1999). Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. Journal of the Neurological Sciences, 166(1), 16-22.
8. Confort-Gouny, S., Vion-Dury, J., Nicoli, F., Dano, P., Donnet, A., Grazziani, N., et al. (1993). A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases. Journal of the Neurological Sciences, 118(2), 123-133.
9. Davie, C. A., Barker, G. J., Thompson, A. J., Tofts, P. S., McDonald, W. I., & Miller, D. H. (1997). 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 63(6), 736-742.
10. Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H., et al. (1994). Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain, 117(Pt 1), 49-58.
11. Davies, S. E., Newcombe, J., Williams, S. R., McDonald, W. I., & Clark, J. B. (1995). High resolution proton NMR spectroscopy of multiple sclerosis lesions. Journal of Neurochemistry, 64(2), 742-748.
12. De Stefano, N., Matthews, P. M., Antel, J. P., Preul, M., Francis, G., & Arnold, D. L. (1995). Chemical pathology of acute demyelinating lesions and its correlation with disability. Annals of Neurology, 38(6), 901-909.
13. Ferguson, B., Matyszak, M. K., Esiri, M. M., & Perry, V. H. (1997). Axonal damage in acute multiple sclerosis lesions. Brain, 120(Pt 3), 393-399.
14. Fernando, K. T., McLean, M. A., Chard, D. T., MacManus, D. G., Dalton, C. M., Miszkiel, K. A., et al. (2004). Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain, 127(Pt 6), 1361-1369.
15. Filippi, M., Campi, A., Dousset, V., Baratti, C., Martinelli, V., Canal, N., et al. (1995). A magnetization transfer imaging study of normal-appearingwhite matter in multiple sclerosis. Neurology, 45(3, Pt 1), 478-482.
16. Fu, L., Matthews, P. M., De Stefano, N., Worsley, K. J., Narayanan, S., Francis, G. S., et al. (1998). Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain, 121(Pt 1), 103-113.
17. Gasperini, C., Horsfield, M. A., Thorpe, J. W., Kidd, D., Barker, G. J., Tofts, P. S., et al. (1996). Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters. Journal of Magnetic Resonance Imaging, 6(4), 580-584.
18. Gonen, O., Catalaa, I., Babb, J. S., Ge, Y., Mannon, L. J., Kolson, D. L., et al. (2000). Total brain N-acetylaspartate: A new measure of disease load in MS. Neurology, 54(1), 15-19.
19. Husted, C. A., Goodin, D. S., Hugg, J. W., Maudsley, A. A., Tsuruda, J. S., de Bie, S. H., et al. (1994). Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Annals of Neurology, 36(2), 157-165.
20. Kapeller, P., McLean, M. A., Griffin, C. M., Chard, D., Parker, G. J., Barker, G. J., et al. (2001). Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. Journal of Neurology, 248(2), 131-138.
21. Larsson, H. B., Christiansen, P., Jensen, M., Frederiksen, J., Heltberg, A., Olesen, J., et al. (1991). Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magnetic Resonance in Medicine, 22(1), 23-31.
22. Loevner, L. A., Grossman, R. I., Cohen, J. A., Lexa, F. J., Kessler, D., & Kolson, D. L. (1995). Microscopic disease in normal-appearingwhite matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology, 196(2), 511-515.
23. Matthews, P. M., Pioro, E., Narayanan, S., De Stefano, N., Fu, L., Francis, G., et al. (1996). Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain, 119(Pt 3), 715-722.
24. McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50(1), 121-127.
25. Moreau, T., Coles, A., Wing, M., Isaacs, J., Hale, G., Waldmann, H., et al. (1996). Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain, 119(Pt 1), 225-237.
26. Narayana, P. A., Doyle, T. J., Lai, D., & Wolinsky, J. S. (1998). Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Annals of Neurology, 43(1), 56-71.
27. Pan, J. W., Hetherington, H. P., Vaughan, J. T., Mitchell, G., Pohost, G. M., & Whitaker, J. N. (1996). Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T. Magnetic Resonance in Medicine, 36(1), 72-77.
28. Patel, T. B., & Clark, J. B. (1979). Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. The Biochemical Journal, 184(3), 539-546.
29. Rooney, W. D., Goodkin, D. E., Schuff, N., Meyerhoff, D. J., Norman, D., & Weiner, M. W. (1997). 1H MRSI of normal appearing white matter in multiple sclerosis. Multiple Sclerosis, 3(4), 231-237.
30. Sarchielli, P., Presciutti, O., Pelliccioli, G. P., Tarducci, R., Gobbi, G., Chiarini, P., et al. (1999). Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain, 122(Pt 3), 513-521.
31. Stewart, V. C., Giovannoni, G., Land, J. M., McDonald, W. I., Clark, J. B., & Heales, S. J. (1997). Pretreatment of astrocytes with interferon-alpha/beta impairs interferon-gamma induction of nitric oxide synthase. Journal of Neurochemistry, 68(6), 2547-2551.
32. Stewart, V. C., Land, J. M., Clark, J. B., & Heales, S. J. (1998). Pretreatment of astrocytes with interferon-alpha/beta prevents neuronal mitochondrial respiratory chain damage. Journal of Neurochemistry, 70(1), 432-434.
33. Suhy, J., Rooney, W. D., Goodkin, D. E., Capizzano, A. A., Soher, B. J., Maudsley, A. A., et al. (2000). 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Multiple Sclerosis, 6(3), 148-155.
34. Tourbah, A., Stievenart, J. L., Gout, O., Fontaine, B., Liblau, R., Lubetzki, C., et al. (1999). Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis. Neurology, 53(5), 1091-1097.
35. van Walderveen, M. A., Barkhof, F., Pouwels, P. J., van Schijndel, R. A., Polman, C. H., & Castelijns, J. A. (1999). Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Annals of Neurology, 46(1), 79-87.
36. van Walderveen, M. A., Truyen, L., van Oosten, B. W., Castelijns, J. A., Lycklama a Nijeholt, G. J., van Waesberghe, J. H., et al. (1999). Development of hypointense lesions on T1-weighted spin-echomagnetic resonance images in multiple sclerosis: relation to inflammatory activity. Archives of Neurology, 56(3), 345-351.